Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Enveric Biosciences Inc ENVB

Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety and addiction disorders. The Company, through Psybrary has created a robust intellectual property (IP) portfolio of new chemical entities for specific mental health indications. Its lead program, the EVM201... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:ENVB)

No current opinion is available.

Bullboard Posts (NDAQ:ENVB)

ENVB....early a.m runner on NR

Lots of volume ......price action not so much
Iseneschal - March 19, 2024

US Companies Moving the Markets, Morning edition <br>Fri, Ma

NEWS: $ENVB US Companies Moving the Markets, Morning edition Fri, Mar 01, 2024 as of 10.00 am ETA look at the top 10 most actives in the...
whytestocks - March 1, 2024

Why Enveric Biosciences Stock Is Soaring | Benzinga

Breaking News: $ENVB Why Enveric Biosciences Stock Is Soaring | BenzingaEnveric Biosciences, Inc. (NASDAQ:ENVB) shares are soaring...
whytestocks - February 29, 2024

Nasdaq Gains 100 Points Following PCE Data | Benzinga

Just In: $ENVB Nasdaq Gains 100 Points Following PCE Data | BenzingaU.S. stocks traded mostly higher this morning, with the Nasdaq...
whytestocks - February 29, 2024

Enveric Biosciences Pursuing Exclusive Out-Licensing of Thre

NEWS: $ENVB Enveric Biosciences Pursuing Exclusive Out-Licensing of Three Classes of Compounds2024-02-29 07:32:31 ET DENVER, Colo., Feb...
whytestocks - February 29, 2024

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue

Breaking News: $ENVB Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of...
whytestocks - February 29, 2024